Haixia Liu
720 Cailun Road
Pudong, 201203, China
Pudong, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Structure-Based Design of Potent TLR7/8/9 Triple Antagonists: Overcoming High Tissue Distribution and Reactive Metabolite Liabilities.
Journal: Journal of medicinal chemistry
Published: July 22, 2026
cGAS-STING signaling in the tumor microenvironment induces myeloid cell activation and favors T cell-mediated antitumor immunity.
Journal: Cancer biology & therapy
Published: November 30, 2025
Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus.
Journal: Journal of medicinal chemistry
Published: October 06, 2023
Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV Infection.
Journal: Journal of medicinal chemistry
Published: March 10, 2023
Small molecule approaches to treat autoimmune and inflammatory diseases (Part II): Nucleic acid sensing antagonists and inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: February 28, 2021
Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
Journal: Antiviral research
Published: December 11, 2020
A synthetic STING agonist inhibits the replication of human parainfluenza virus 3 and rhinovirus 16 through distinct mechanisms.
Journal: Antiviral research
Published: July 22, 2020
Repurposing a Library of Human Cathepsin L Ligands: Identification of Macrocyclic Lactams as Potent Rhodesain and Trypanosoma brucei Inhibitors.
Journal: Journal of medicinal chemistry
Published: March 30, 2018
Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection.
Journal: ACS infectious diseases
Published: January 26, 2018
Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors.
Journal: Journal of medicinal chemistry
Published: March 25, 2017
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors.
Journal: Journal of medicinal chemistry
Published: July 27, 2016
Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 01, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026